Molecular docking and structure-activity relationship studies on benzothiazole based non-peptidic BACE-1 inhibitors.
about
BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's diseaseIn Silico Design of Beta-Secretase Inhibitors in Alzheimer's Disease.Developing β-secretase inhibitors for treatment of Alzheimer's disease.The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors.Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.
P2860
Molecular docking and structure-activity relationship studies on benzothiazole based non-peptidic BACE-1 inhibitors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Molecular docking and structur ...... on-peptidic BACE-1 inhibitors.
@en
Molecular docking and structur ...... on-peptidic BACE-1 inhibitors.
@nl
type
label
Molecular docking and structur ...... on-peptidic BACE-1 inhibitors.
@en
Molecular docking and structur ...... on-peptidic BACE-1 inhibitors.
@nl
prefLabel
Molecular docking and structur ...... on-peptidic BACE-1 inhibitors.
@en
Molecular docking and structur ...... on-peptidic BACE-1 inhibitors.
@nl
P2093
P1476
Molecular docking and structur ...... non-peptidic BACE-1 inhibitors
@en
P2093
Weiliang Zhu
P304
P356
10.1016/J.BMCL.2010.08.111
P407
P50
P577
2010-08-27T00:00:00Z